Phase II Study of FOLFIRI Plus Bevacizumab (AVASIRI) in Patients as Second Line Chemotherapy of Unresectable Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: 5-FU, CPT-11, Bevacizumab Primary outcome(s): Assessment of overall response rate (ORR; complete response [CR] + partial response [PR]). Study Design: Single arm Non-randomized
创建时间：
2008-02-15
